Parallel Advisors, LLC Zoetis Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 37,783 shares of ZTS stock, worth $6.68 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

37,783

Previous 37,761 0.06%

Holding current value

$6.68 Million

Previous $6.55 Million 12.77%

% of portfolio

0.18%

Previous 0.17%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$172.58 - $196.48 $3,796 - $4,322	22 Added 0.06%	37,783 $7.38 Million
Q2 2024 Aug 08, 2024	BUY	$145.54 - $178.83 $192,112 - $236,055	1,320 Added 3.62%	37,761 $6.55 Million
Q1 2024 May 06, 2024	SELL	$165.67 - $199.94 $268,054 - $323,502	-1,618 Reduced 4.25%	36,441 $6.17 Million
Q4 2023 Feb 09, 2024	BUY	$151.44 - $200.09 $61,636 - $81,436	407 Added 1.08%	38,059 $7.51 Million
Q3 2023 May 20, 2024	BUY	$167.14 - $192.77 $370,215 - $426,985	2,215 Added 6.25%	37,652 $6.55 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $370,215 - $426,985	2,215 Added 6.25%	37,652 $6.55 Million
Q2 2023 May 20, 2024	BUY	$160.94 - $186.23 $256,538 - $296,850	1,594 Added 4.71%	35,437 $6.1 Million
Q2 2023 Aug 04, 2023	BUY	$160.94 - $186.23 $256,538 - $296,850	1,594 Added 4.71%	35,437 $6.1 Million
Q1 2023 May 20, 2024	SELL	$145.48 - $175.02 $377,957 - $454,701	-2,598 Reduced 7.13%	33,843 $5.63 Million
Q1 2023 Apr 25, 2023	BUY	$145.48 - $175.02 $4.31 Million - $5.19 Million	29,643 Added 705.79%	33,843 $5.63 Million
Q4 2022 Feb 03, 2023	SELL	$131.14 - $157.47 $50,882 - $61,098	-388 Reduced 8.46%	4,200 $615,000
Q3 2022 Nov 10, 2022	SELL	$148.29 - $182.55 $33,068 - $40,708	-223 Reduced 4.64%	4,588 $680,000
Q2 2022 Aug 01, 2022	SELL	$155.97 - $200.09 $39,148 - $50,222	-251 Reduced 4.96%	4,811 $827,000
Q1 2022 Apr 28, 2022	SELL	$181.39 - $234.03 $92,146 - $118,887	-508 Reduced 9.12%	5,062 $968,000
Q4 2021 Jan 20, 2022	BUY	$193.69 - $247.03 $107,885 - $137,595	557 Added 11.11%	5,570 $1.36 Million
Q3 2021 Nov 02, 2021	BUY	$189.29 - $209.69 $46,565 - $51,583	246 Added 5.16%	5,013 $973,000
Q2 2021 Aug 06, 2021	BUY	$155.9 - $187.99 $60,489 - $72,940	388 Added 8.86%	4,767 $888,000
Q1 2021 Apr 23, 2021	SELL	$144.0 - $169.39 $6,192 - $7,283	-43 Reduced 0.97%	4,379 $690,000
Q4 2020 Feb 02, 2021	SELL	$157.07 - $174.35 $18,848 - $20,922	-120 Reduced 2.64%	4,422 $732,000
Q3 2020 Oct 27, 2020	BUY	$137.1 - $165.37 $138,608 - $167,189	1,011 Added 28.63%	4,542 $751,000
Q2 2020 Jul 16, 2020	BUY	$111.92 - $142.53 $7,162 - $9,121	64 Added 1.85%	3,531 $483,000
Q1 2020 Apr 27, 2020	BUY	$92.66 - $144.94 $19,643 - $30,727	212 Added 6.51%	3,467 $408,000
Q4 2019 Jan 30, 2020	BUY	$116.25 - $133.25 $17,902 - $20,520	154 Added 4.97%	3,255 $431,000
Q3 2019 Nov 01, 2019	BUY	$112.57 - $128.43 $31,744 - $36,217	282 Added 10.0%	3,101 $386,000
Q2 2019 Aug 05, 2019	BUY	$97.98 - $114.28 $4,507 - $5,256	46 Added 1.66%	2,819 $320,000
Q1 2019 May 01, 2019	SELL	$81.56 - $100.67 $4,730 - $5,838	-58 Reduced 2.05%	2,773 $279,000
Q4 2018 Feb 05, 2019	SELL	$79.28 - $95.27 $4,598 - $5,525	-58 Reduced 2.01%	2,831 $242,000
Q3 2018 Nov 01, 2018	SELL	$83.5 - $93.23 $10,354 - $11,560	-124 Reduced 4.12%	2,889 $265,000
Q2 2018 Jul 30, 2018	BUY	$79.9 - $89.2 $62,801 - $70,111	786 Added 35.29%	3,013 $256,000
Q1 2018 May 08, 2018	SELL	$71.51 - $84.69 $1,144 - $1,355	-16 Reduced 0.71%	2,227 $186,000
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $4,995 - $5,751	79 Added 3.65%	2,243 $162,000
Q3 2017 Nov 15, 2017	BUY	$59.73 - $65.4 $129,255 - $141,525	2,164 New	2,164 $149,000
Q3 2017 Nov 14, 2017	SELL	$59.73 - $65.4 $135,168 - $148,000	-2,263 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	2,263	2,263 $141,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Zoetis Inc. Transaction History